作者:
Roos S G SablerollesFrom the Departments of Internal Medicine (R.S.G.S.
M.L.) Hospital Pharmacy (R.S.G.S. W.J.R.R. P.H.M.K.) and Viroscience (D.G. K.S.S. M.P.G.K. C.H.G. R.D.V.) and the Department of Internal Medicine Division of Allergy and Clinical Immunology and Department of Immunology (V.A.S.H.D.) Erasmus University Medical Center Rotterdam the Center of Tropical Medicine and Travel Medicine Department of Infectious Diseases (A.G. H.M.G.G.) and the Department of Experimental Immunology Amsterdam University Medical Centers Amsterdam Institute for Infection and Immunity University of Amsterdam (N.A.K.) Amsterdam the Department of Internal Medicine and Infectious Diseases (D.F.P.) and the Department of Medical Microbiology and Infection Prevention University Medical Center Groningen University of Groningen (A.L.W.H. D.B.) Groningen the Department of Infectious Diseases Leiden University Medical Center Leiden (L.G.V.) and the Center for Infectious Disease Control National Institute for Public Health and the Environment Bilthoven (D.B.) - all in the Netherlands.
Background:The ***2.S vaccine,which was approved as a single-shot immunization regimen,has been shown to be effective against severe coronavirus disease ***,this vaccine induces lower severe acute respiratory syndrome...
详细信息
Background:The ***2.S vaccine,which was approved as a single-shot immunization regimen,has been shown to be effective against severe coronavirus disease ***,this vaccine induces lower severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)spike protein(S)-specific antibody levels than those induced by messenger RNA(mRNA)-based *** immunogenicity and reactogenicity of a homologous or heterologous booster in persons who have received an ***2.S priming dose are unclear.
作者:
J.RaynerCheung C.L.G.J.SmithR.G.WebsterJ.S.M.Peiris陈鸿霖State Key Laboratory of Emerging Infectious Diseases
Department of MicrobiologyThe University of Hong KongFaculty of Medicine Building 21 Sassoon Road Pokfulam Hong Kong SARChina Joint Influenza Research Center (SUMC & HKU)Shantou University Medical CollegeShantouGuangdong 515031 China State Key Laboratory of Emerging Infectious Diseases
Department of MicrobiologyThe University of Hong Kong Faculty of Medicine Building 21 Sassoon RoadPokfulamHong Kong SARChina Joint Influenza Research Center (SUMC & HKU)Shantou University Medical CollegeShantouGuangdong 515031China State Key Laboratory of Emerging Infectious Diseases
Department of MicrobiologyThe University of Hong KongFaculty of Medicine Building21 Sassoon RoadPokfulamHong Kong SARChina Virology DivisionDepartment of Infectious DiseasesSt Jude Children’s Research HospitalMemphisTN 38105USA State Key Laboratory of Emerging Infectious Diseases
Department of MicrobiologyThe University of Hong KongFaculty of Medicine Building21 Sassoon RoadPokfulamHong Kong SARChina Joint Influenza Research Center (SUMC & HKU)Shantou University Medical CollegeShantouGuangdong 515031China
H5N1 avian influenza virus is expanding its geographical distribution and human infections are being repeatedly detected in affected countries. Stockpiling antiviral drugs has been considered as a component of prepare...
H5N1 avian influenza virus is expanding its geographical distribution and human infections are being repeatedly detected in affected countries. Stockpiling antiviral drugs has been considered as a component of preparedness for a potential H5N1 influenza pandemic. However, resistance to amantadine, an ion channel blocker, has been identified in the majority of isolates from some affected countries. While the stockpiling of the neuraminidase inhibitor oseltamivir has been started in many countries, viral resistance has been detected in some patients with H5N1 disease being treated with oseltamivir. Resistance to anti-influenza virus drugs is a matter of great concern and relevance for pandemic preparedness.
As a result of fundamental changes in the International Code of Nomenclature on the use of separate names for sexual and asexual stages of fungi,generic names of many groups should be *** of the ECMM/ISHAM working gro...
详细信息
As a result of fundamental changes in the International Code of Nomenclature on the use of separate names for sexual and asexual stages of fungi,generic names of many groups should be *** of the ECMM/ISHAM working group on Pseudallescheria/Scedosporium infections herein advocate a novel nomenclature for genera and species in Pseudallescheria,Scedosporium and allied *** generic names Parascedosporium,Lomentospora,Petriella,Petriellopsis,and Scedosporium are proposed for a lineage within Microascaceae with mostly Scedosporium anamorphs producing slimy,annellidic *** that Scedosporium has priority over Pseudallescheria and that Scedosporium prolificans is phylogenetically distinct from the other Scedosporium species,some name changes are *** minutispora and Petriellidium desertorum are renamed as Scedosporium minutisporum and ***,*** prolificans is renamed as Lomentospora prolificans.
暂无评论